While the clinical definition of multidrug-resistant and extensively drug-resistant tuberculosis covers resistance to isoniazid, rifampin, fluoroquinolones, and the injectable drugs, drug resistance testing for other first- and second-line agents, against which clinical resistance may be significant, is not commonly included in national surveys.
1
—
—